Literature DB >> 24037981

Serology indicates cytomegalovirus infection is associated with varicella-zoster virus reactivation.

Benson Ogunjimi1, Heidi Theeten, Niel Hens, Philippe Beutels.   

Abstract

Varicella-zoster virus (VZV) causes chickenpox after which the virus remains latent in neural ganglia. Subsequent reactivation episodes occur, leading mainly to subclinical detection of VZV, but also to the clinical entity herpes zoster. These reactivations are known to occur most frequently amongst immunocompromised individuals, but the incidence of herpes zoster is also known to increase with age, supposedly as a consequence of immunosenescence. Our analysis aims to explore associations between cytomegalovirus (CMV) infection and VZV reactivation by analyzing VZV-specific antibody titers as a function of age, gender, and CMV serostatus. The analysis was repeated on measles and parvovirus B19 antibody titers. At the time of the observations, measles virus circulation was virtually eliminated, whereas parvovirus B19 circulated at lower levels than VZV. Multiple linear regression analyses, using the log-transformed antibody titers, identified a positive association between ageing and VZV antibody titers suggesting that ageing increasingly stimulates VZV reactivation. CMV infection further amplified the positive association between ageing and the reactivation rate. A negative association between CMV infection and VZV antibody titers was found in young individuals, thereby supporting the hypothesis that CMV infection may have a negative effect on the number of B-cells. However, no associations between CMV infection and measles or parvovirus B19 antibody titers occurred, but ageing tended to be associated with a decrease in the antibody titer against parvovirus B19. The combined results thus suggest that both CMV-dependent and CMV-independent immunosenescence occurs. This is supported by an in-depth analysis of VZV, measles and parvovirus B19 antibody titers.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  CMV; herpes zoster; immunosenescence; measles; parvovirus; reactivation

Mesh:

Substances:

Year:  2013        PMID: 24037981     DOI: 10.1002/jmv.23749

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  16 in total

1.  Cytomegalovirus seropositivity is associated with herpes zoster.

Authors:  Benson Ogunjimi; Niel Hens; Richard Pebody; Hilde Jansens; Holly Seale; Mark Quinlivan; Heidi Theeten; Herman Goossens; Judy Breuer; Philippe Beutels
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  The Epidemiology of Herpes Zoster After Varicella Immunization Under Different Biological Hypotheses: Perspectives From Mathematical Modeling.

Authors:  Giorgio Guzzetta; Piero Poletti; Stefano Merler; Piero Manfredi
Journal:  Am J Epidemiol       Date:  2016-03-18       Impact factor: 4.897

3.  VZV encephalitis following successful treatment of CMV infection in a patient with kidney transplant.

Authors:  Shahzaib Nabi; Pushpinderdeep Kahlon; Mariella Goggins; Anita Patel
Journal:  BMJ Case Rep       Date:  2014-12-02

Review 4.  Varicella vaccination - the global experience.

Authors:  Peter Wutzler; Paolo Bonanni; Margaret Burgess; Anne Gershon; Marco Aurélio Sáfadi; Giacomo Casabona
Journal:  Expert Rev Vaccines       Date:  2017-07-13       Impact factor: 5.217

5.  Influence of frequent infectious exposures on general and varicella-zoster virus-specific immune responses in pediatricians.

Authors:  Benson Ogunjimi; Evelien Smits; Steven Heynderickx; Johan Van den Bergh; Joke Bilcke; Hilde Jansens; Ronald Malfait; Jose Ramet; Holden T Maecker; Nathalie Cools; Philippe Beutels; Pierre Van Damme
Journal:  Clin Vaccine Immunol       Date:  2014-01-15

6.  Cellular Interferon Gamma and Granzyme B Responses to Cytomegalovirus-pp65 and Influenza N1 Are Positively Associated in Elderly.

Authors:  Heidi Theeten; Catharina Mathei; Kelly Peeters; Benson Ogunjimi; Herman Goossens; Margareta Ieven; Pierre Van Damme; Nathalie Cools
Journal:  Viral Immunol       Date:  2016-03-22       Impact factor: 2.257

Review 7.  Herpes Zoster Risk Reduction through Exposure to Chickenpox Patients: A Systematic Multidisciplinary Review.

Authors:  Benson Ogunjimi; Pierre Van Damme; Philippe Beutels
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

8.  Control of varicella in the post-vaccination era in Australia: a model-based assessment of catch-up and infant vaccination strategies for the future.

Authors:  Z Gao; J G Wood; H F Gidding; A T Newall; R I Menzies; H Wang; P B McIntyre; C R MacIntyre
Journal:  Epidemiol Infect       Date:  2014-09-15       Impact factor: 4.434

9.  Increased herpes zoster risk associated with poor HLA-A immediate early 62 protein (IE62) affinity.

Authors:  Pieter Meysman; Nicolas De Neuter; Esther Bartholomeus; George Elias; Johan Van den Bergh; Marie-Paule Emonds; Geert W Haasnoot; Steven Heynderickx; Johan Wens; Nele R Michels; Julien Lambert; Eva Lion; Frans H J Claas; Herman Goossens; Evelien Smits; Pierre Van Damme; Viggo Van Tendeloo; Philippe Beutels; Arvid Suls; Geert Mortier; Kris Laukens; Benson Ogunjimi
Journal:  Immunogenetics       Date:  2017-12-01       Impact factor: 3.330

10.  Integrating between-host transmission and within-host immunity to analyze the impact of varicella vaccination on zoster.

Authors:  Benson Ogunjimi; Lander Willem; Philippe Beutels; Niel Hens
Journal:  Elife       Date:  2015-07-11       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.